Using quality improvement to implement the CNS/AAN quality measure on rescue medication for seizures. (16th October 2020)

• Record Type: Journal Article
• Authors: Patel, Anup D.; Herbst, James; Gibson, Annika; Karn, Mary; Terry, Debbie; Debs, Andrea; Yarosz, Shannon; Parker, William; Cohen, Daniel M.
• Is Part Of: Epilepsia. Volume 61:issue 12(2020)
• Page Start: 2712
• Page End: 2719
• Publication Date: 2020-10-16
• Subjects: epilepsy -- interventions -- medication -- quality improvement -- rescue; Epilepsy -- Periodicals; 616.853
• DOI: 10.1111/epi.16713
• Languages: English
• ISSNs: 0013-9580

Abstract

Abstract: Objective: A multidisciplinary quality improvement (QI) team was established to conduct analysis of data for prescribed seizure rescue medication doses from January 2013 to December 2015 to identify and improve inappropriately low dose prescriptions. The QI team identified areas of focus for improvement opportunities and developed the project objective based on the 2017 American Academy of Neurology (AAN) and Child Neurology Society (CNS) quality measure. Methods: Within a freestanding children's hospital, the QI team developed key drivers and implemented interventions, such as the midazolam prefilled syringe program with use of standardized dosing, electronic chart tools, monthly pharmacy review of all underdosed prescriptions, and provider and nursing education. The team created an automated monthly report to monitor prescribed seizure rescue medication dosing compliance. The year 2015 was used as the preliminary data baseline period with an average noncompliance rate of 3.5%. Results: From January 2016 to December 2019, the team has decreased and sustained the noncompliance rate to an average of 0.38%. The data for the project included 12, 975 seizure rescue medication prescribed by a neurology provider from January 2015 to December 2019. Compliance with properly dosed diazepam orders continues to be the largest area of opportunity. The data demonstrated a centerline shift in January 2019, moving the baseline average of 7.2% noncompliance to the current average rate of 0.22%. In comparison, underdosed midazolam orders occurred at an average rate of 0.037% in the same timeframe. Significance: Using quality improvement methodologies, the team successfully and substantially decreased provider prescribed and signed underdosed rescue medication orders by an average of 89%. This QI project demonstrates successful implementation and improvement addressing the AAN/CNS quality measure of proper rescue seizure treatment dosing.